Gossamer Bio (GOSS) Interest Coverage Ratio (2018 - 2026)
Gossamer Bio (GOSS) posted quarterly Interest Coverage Ratio of 8.71 for Q1 2026, up 35.0% year-over-year from 6.45 in Q1 2025, and down 13.35% quarter-over-quarter from 7.69 in Q4 2025.
Gossamer Bio (GOSS) Interest Coverage Ratio (2018 - 2026) Analysis & Trends
Gossamer Bio's Interest Coverage Ratio history runs 9 years deep, the most recent figure standing at 8.71 for Q1 2026.
- In Q1 2026, Interest Coverage Ratio rose 35.0% year-over-year to 8.71; the TTM figure through Mar 2026 stood at 34.72 (down 749.26% YoY), while the FY2025 annual figure was 0.62, down 138.08% from the prior year.
- Interest Coverage Ratio for Q1 2026 stood at 8.71, down from 7.69 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 17.86 in Q2 2024, with the low at 16.12 in Q3 2022.
- The 5-year median for Interest Coverage Ratio is 12.41 (2024), against an average of 9.58.
- The sharpest annual moves came in 2024 and 2025: Interest Coverage Ratio surged 232.29% in 2024, then tumbled 132.25% in 2025.
- Gossamer Bio's Interest Coverage Ratio stood at 9.59 in 2022, then plunged by 57.89% to 15.14 in 2023, then jumped by 52.26% to 7.23 in 2024, then declined by 6.39% to 7.69 in 2025, then fell by 13.35% to 8.71 in 2026.
- Business Quant data shows GOSS's Interest Coverage Ratio at 8.71 in Q1 2026, 7.69 in Q4 2025, and 0.75 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 2.82 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -0.08 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 1.42 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 76.86 |
| 10 | Gossamer Bio | 50.34 Mn | -6.69 Mn | - | -9.64 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -5.46 |
| Mar 31, 2026 | -8.71 |
| Dec 31, 2025 | -7.69 |
| Sep 30, 2025 | -0.75 |
| Jun 30, 2025 | -5.76 |
| Mar 31, 2025 | -13.40 |
| Dec 31, 2024 | -7.23 |
| Sep 30, 2024 | -12.41 |
| Jun 30, 2024 | 17.86 |
| Mar 31, 2024 | -13.41 |
| Dec 31, 2023 | -15.14 |
| Sep 30, 2023 | -12.11 |
| Jun 30, 2023 | -13.50 |
| Mar 31, 2023 | -13.70 |
| Dec 31, 2022 | -9.59 |
| Sep 30, 2022 | -16.12 |
| Jun 30, 2022 | -15.48 |
| Mar 31, 2022 | -15.67 |
| Dec 31, 2021 | -10.46 |
| Sep 30, 2021 | -11.39 |